Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04947813

Genotype-Phenotype Correlations in Patients With Alport Syndrome

Association Analysis Between Variants of COL4A3/COL4A4/COL4A5 and Alport Syndrome in the Han Chinese Population

Status
Recruiting
Phase
Study type
Observational
Enrollment
8,165 (estimated)
Sponsor
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Alport syndrome (AS) is caused by pathogenic variants in the type IV collagen genes COL4A3, COL4A4, and COL4A5. This study aims to enroll families and patients with a history of renal hematuria in 27 hospitals and detect these three genes for AS screening. This study also aims to analysis the effect of COL4A3/COL4A4/COL4A5 genotype on the development of kidney disease.

Detailed description

Alport syndrome (AS) is a genetically and phenotypically heterogeneous disorder caused by the mutations in the type IV collagen genes COL4A3, COL4A4, and COL4A5. In this study, next generation sequencing is used to screen AS on 8165 participants enrolled from families and patients with a history of renal hematuria in 27 hospitals of China Huadong Region. Genotype (variants in COL4A3/COL4A4/COL4A5)-phenotype (onset age of hearing loss, nephroticrange proteinuria, decline of eGFR, kidney survival and onset age of CKD5) correlations in AS were evaluated.

Conditions

Timeline

Start date
2021-01-01
Primary completion
2025-12-31
Completion
2030-12-31
First posted
2021-07-01
Last updated
2021-07-01

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04947813. Inclusion in this directory is not an endorsement.